Loading company…
Oncomedics develops predictive tests to personalize anti-tumoral treatment, based in Limoges, France.
Founded in 2006 in Limoges, France, Oncomedics develops predictive testing for oncology to help personalize anti-tumoral treatment. The company has raised a total of EUR 0.778 mn, including EUR 777,600 in venture funding from individual investors in February 2024. Its current valuation is EUR 7.615 mn, and its recorded stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in